Navigation Links


Domain at Biology News

Novel EGFR ectodomain mutations in glioblastoma

The Epidermal Growth Factor Receptor (EGFR), a so-called kinase protein, is often abnormally active in cancer. A new class of anticancer drugs inhibiting the activated EGFR kinase have shown to be effective against such cancers, especially lung cancer. In a new study in PLoS Medicine, researchers have catalogued and characterized the mutations in the EGFR gene that occur in glioblastoma, a deadly...
Domain at Biology Products

Mouse Anti-Human Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4) Monoclonal Antibody, Unconjugated from Lifespan Biosciences

Description:Mouse Anti-Human Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4 Monoclonal Antibody New...
Company:Lifespan Biosciences

Human MMP-14 [MT1-MMP], Catalytic Domain, E. coli recombinant from CHEMICON

Description:CC1041 is a recombinant 177 amino acid polypeptide sequence corresponding to Tyr89 Gly265 of mature human MT1-MMP. Produced by activation of a recombinant soluble proform of MT1-MMP purified from E. coli periplasm. SPECIFIC ACTIVITY:The specific activity of MT1-MMP catalytic domain is = 140 mU/mg, where 1 U is the activity that hydrolyzes 1 mol peptide (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gl...
Company:CHEMICON

Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2) Monoclonal Antibody, Unconjugated from Lifespan Biosciences

Description:Mouse Anti-Human Methyl-CpG binding domain protein 2 (MBD2 Monoclonal Antibody Western Blot...
Company:Lifespan Biosciences

Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences

Description:Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Flow Cytometry...
Company:Lifespan Biosciences

Mouse Anti-PSD-95, PDZ Domain Monoclonal Antibody, Unconjugated, Clone K28/86.2 from Upstate

Description:Anti-PSD-95, clone K28/86.2, PDZ Domain Recognizes PDZ domains of PSD-95, SAP97 and Chapsyn 110/PS...
Company:Upstate

More>>

Domain at Biology Technology

Use of FlashPlate Technology for In Vitro Measurement of 125I-Labeled TGF-1 Binding on Chimeric Extracellular Domain of Type II Transforming Growth Factor Receptor

Dpartement dImmunologie, Laboratoires Fournier S.A., France TGF- type I and type II receptors form ligand dependent heteromeric signaling complexes, in which transforming growth factor- receptor type II (TRII) tends to act as the primary receptor....

Early Stage Step 2: Choosing a domain name

- So now that you know you have a patentable technol...

Is your business domain at risk?

These are questions posed by a reader regarding domains in his portfolio. Alth...

Renew your domain name!

The domai...

Rice Centromere, Supposedly Quiet Genetic Domain, Surprises

MADISON - Probing the last genomic frontier of higher organisms, an international team of scientists has succeeded in sequencing a little understood - but critical - genetic domain in rice. In doing so, the group, led by Jiming Jiang, a professor of horticulture at the , and C. Robin Buell of the <a href="h...
Domain at Biology Dictionary

Domain

a <A href="http:/ / w...
Domain at Medicine News

India to maintain Public domain Registry database of clinical trials conducted in India.

India to set up a registry database which will contain all datas and research results of all clinical trials which would be available in a public domain which will provide transparent results and information for patients.// The detail of the new registry database was announced by Drug Controller General of India Ashwani Kumar. He announced the details of the registry during a two day work...
Domain at Medicine Products

RTVue-100 Fourier-Domain Optical Coherence Tomography (OCT)

Description:RTVue is an ultra-high speed, high resolution optical coherence tonometry (OCT) retina scanner used for retina imaging and analysis. It is based on the next generation Fourier-Domain Optical Coherence technology just emerging from clinical research in the last two years. The ultra-high speed and high resolution features enable the FD-OCT to visualize the retinal tissue with ultra-high clarity...
Company:Optovue Corporation
Domain at Medicine Technology
Other TagsWesternWesternWesternWesternWestern
(Date:10/11/2008)... Barnett International, a... has announced the release of The Form FDA 1572: A...s, and Monitors. Designed for clinical investigato...y affairs professionals, and others involved in th... reference guide to address the Form FDA 1572-Stat...
(Date:10/10/2008)... PACO Communications Named Agency ...gian American Hospital has just,announced the laun...signed,to build awareness of its long-standing com... and care through its Labor and Delivery, Special ... rolled out in Chicago with a focus on public rela...
(Date:10/10/2008)...1 in 6 likely to develop some form of disease by 2...FRIDAY, Oct. 10 (HealthDay News) -- Liver transpla... the general population, say researchers in Finlan...ssue of Liver Transplantation , researchers inves...er transplant recipients from Helsinki University ...
(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/...unces that it has appointed William,(Bill) Federic...ard to five,members., Mr. Federici joined West Ph...Financial Officer in August of 2003. Under his fin...have grown to more than $1.0 billion from,$300 mil...
Breaking Medicine News(10 mins):Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 2Health News:Barnett Releases Reference Guide on Form FDA 1572--Statement of Investigator 3Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 2Health News:Norwegian American Hospital Launches Awareness Campaign Targeting Hispanic, African-American and General-Market Moms 3Health News:Liver Transplant Patients at Higher Cancer Risk 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3
(Date:10/10/2008)...Haven, Conn. Yale scientists have created nanowir...ronics that are both sensitive and specific enough...ion, according to a report in Nano Letters . , ...ly specific antigens signatures of bacteria, viru... are activated, they produce acid, and generate a ...
(Date:10/9/2008)...NTA CLARA, Calif., Oct. 9 /PRNewswire-FirstCall/ -...ading developer of human interface,solutions for m... devices,announced today that it will report fina... on Thursday, October 23, 2008 after the close of ...erence call for analysts and,investors at 2:00 p.m...
(Date:10/9/2008)...It,s hard being a mussel: you have to worry about ...ention an environment that can change your body te...s. , "It,s one of the most variable habitats on ... can spend part of the day bathed in cool Pacific ...rnia sun." , Gracey led the first real-time mole...
(Date:10/9/2008)...National Institute of Allergy and Infectious Disea...alth (NIH), will award five-year contracts estimat... in Systems Biology for Infectious Disease Researc...h facility will apply novel techniques to study di...ome (SARS), tuberculosis and influenza. , System...
Breaking Biology News(10 mins):Sensitive nanowire disease detectors made by Yale scientists 2Synaptics to Report First Quarter Results on October 23 2Brainy genes, not brawn, key to success on mussel beach 2Brainy genes, not brawn, key to success on mussel beach 3New Systems Biology Awards enable detailed study of microbes 2Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 1Viant Appoints Keith Vangeison as Executive Vice President of Network Development 6675 2Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 1Study Finds a Lack of Health Insurance May Roadblock Some Diabetes Patients From Seeking Critical Treatment 6671 2Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 1Marketing and Meeting Details 28M2D 29 Officially Launches an Innovative Life Sciences Marketing and Communications Company 6667 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 1Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 2Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 3Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 4Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 5Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 6Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE 28R 29 28Irbesartan Hydrochlorothiazide 29 a 879 7
Other Contentsextantextantextensorfamilialfamilialfamilialfamilialfamilialfallopianfallopianfallopianfasciafasciafatsfatsfatsfatsfats